These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27871461)

  • 21. Bromodomain protein BRD4 is increased in human placentas from women with early-onset preeclampsia.
    Liong S; Barker G; Lappas M
    Reproduction; 2018 Jun; 155(6):573-582. PubMed ID: 29748248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants.
    Royle C; Lim S; Xu B; Tooher J; Ogle R; Hennessy A
    Cytokine; 2009 Jul; 47(1):56-60. PubMed ID: 19501525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
    Li H; Gu B; Zhang Y; Lewis DF; Wang Y
    Placenta; 2005; 26(2-3):210-7. PubMed ID: 15708122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Nguyen TV; Tuohey L; Cluver C; Tong S; Kaitu'u-Lino TJ
    Placenta; 2020 Jun; 95():78-83. PubMed ID: 32452405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.
    Hannan NJ; Brownfoot FC; Cannon P; Deo M; Beard S; Nguyen TV; Palmer KR; Tong S; Kaitu'u-Lino TJ
    Sci Rep; 2017 May; 7(1):1819. PubMed ID: 28500309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
    Kaitu'u-Lino TJ; Brownfoot FC; Beard S; Cannon P; Hastie R; Nguyen TV; Binder NK; Tong S; Hannan NJ
    PLoS One; 2018; 13(2):e0188845. PubMed ID: 29466360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
    Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
    Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
    J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia.
    Chang X; He Q; Wei M; Jia L; Wei Y; Bian Y; Duan T; Wang K
    Eur J Med Res; 2023 Aug; 28(1):277. PubMed ID: 37559150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
    Rahman RA; Murthi P; Singh H; Gurungsinghe S; Leaw B; Mockler JC; Lim R; Wallace EM
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells.
    Lin L; Li G; Zhang W; Wang YL; Yang H
    J Cell Physiol; 2019 Aug; 234(10):18928-18941. PubMed ID: 31004367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.
    Onda K; Tong S; Beard S; Binder N; Muto M; Senadheera SN; Parry L; Dilworth M; Renshall L; Brownfoot F; Hastie R; Tuohey L; Palmer K; Hirano T; Ikawa M; Kaitu'u-Lino T; Hannan NJ
    Hypertension; 2017 Mar; 69(3):457-468. PubMed ID: 28115513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of preeclampsia.
    Matsubara K; Nagamatsu T; Fujii T; Kozuma S; Taketani Y
    J Reprod Immunol; 2005 Dec; 68(1-2):27-37. PubMed ID: 16229897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes.
    Spiel M; Salahuddin S; Pernicone E; Zsengeller Z; Wang A; Modest AM; Karumanchi SA; Hecht JL
    Placenta; 2017 Apr; 52():10-16. PubMed ID: 28454690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfasalazine decreases soluble fms-like tyrosine kinase-1 secretion potentially via inhibition of upstream placental epidermal growth factor receptor signalling.
    Hastie R; Brownfoot FC; Cannon P; Nguyen V; Tuohey L; Hannan NJ; Tong S; Kaitu'u-Lino TJ
    Placenta; 2019 Nov; 87():53-57. PubMed ID: 31561065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells.
    Eddy AC; Chapman H; Brown DT; George EM
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.